Our data demonstrate that treatment with PD1+CXCL13+CD8+T cells effectively reduces the growth of HNSCC tumors compared to PD1+CXCL13-CD8+T cells (Figures 6G–I). This evidence concerns the gene CD8A and head and neck squamous cell carcinoma.